Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.4%

125 terminated/withdrawn out of 1011 trials

Success Rate

82.8%

-3.8% vs industry average

Late-Stage Pipeline

13%

129 trials in Phase 3/4

Results Transparency

45%

270 of 600 completed trials have results

Key Signals

180 recruiting270 with results97 terminated28 withdrawn

Enrollment Performance

Analytics

N/A

452(57.4%)

Phase 2

124(15.8%)

Phase 4

90(11.4%)

Phase 1

67(8.5%)

Phase 3

39(5.0%)

Early Phase 1

15(1.9%)

787Total

N/A(452)

Phase 2(124)

Phase 4(90)

Phase 1(67)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1011)

Showing 20 of 1011 trials

NCT05833048Not ApplicableRecruiting

Rectus Sheath Block in Cardiac Surgery

Role: lead

NCT05519137Not ApplicableCompleted

Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia

Role: lead

NCT03304080Phase 1Active Not Recruiting

Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast

Role: lead

NCT05188118Early Phase 1Completed

Rapid Sequencing of Approved Therapies in Patients With Metastatic or Unresectable Clear Cell Renal Cell Carcinoma

Role: lead

NCT07734090Not Yet Recruiting

Natural History of MADD

Role: lead

NCT02055248Completed

Study on Moebius Syndrome and Congenital Facial Weakness Disorders

Role: collaborator

NCT07651956Phase 4Not Yet Recruiting

Remimazolam Versus Dexmedetomidine for Sedation During Neuraxial

Role: lead

NCT07730853Not ApplicableNot Yet Recruiting

Isocaloric Navy-Bean Substitution in Adults With MASLD

Role: lead

NCT06809140Phase 2Recruiting

Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer

Role: collaborator

NCT06133114Phase 4Withdrawn

Psychopharmacological Treatment of Emotional Distress

Role: lead

NCT07197840Recruiting

The CHALLENGER Registry

Role: lead

NCT07059494Phase 4Recruiting

Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant

Role: lead

NCT01816152Not ApplicableCompleted

Methodology Issues in a Tailored Light Treatment for Persons With Dementia

Role: lead

NCT06398847Not ApplicableRecruiting

Virtual Reality (VR) Self-Hypnosis Software

Role: lead

NCT06259097Phase 3Recruiting

Different Medications to Induce Labor

Role: lead

NCT06858787Not ApplicableRecruiting

Validating CGM for GDM

Role: lead

NCT04112186Not ApplicableCompleted

Mindfulness-Oriented Recovery Enhancement (MORE) in Heroin Addiction

Role: lead

NCT07291427Recruiting

Chronic Subdural Hematoma Embolization With Detachable Coils

Role: lead

NCT02328573Not ApplicableRecruiting

The Impact of Group Singing on Patients With Stroke and Their Personal Caregivers

Role: lead

NCT03533985Not ApplicableRecruiting

Effect of Music Therapy on Infants With Neonatal Abstinence Syndrome

Role: lead